Stylianos Michalakis Professor of Ocular Gene Therapy, Department of Ophthalmology at Ludwig-Maximilians-Universität München (LMU Medical Center), Munich, Germany.
Unnatural Selection May 27, 2021 Novel gene vectors delivered by intravitreal rather than subretinal injection may represent a lower-risk option for retinal dystrophy patients 1 min read